Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Agouron's HIV protease inhibitor approved for marketing in Canada

Aug. 26, 1998

NIAID will collaborate with VaxGen on phase III AIDSVAX studies

Aug. 21, 1998

PKA I may be a valid target for immunomodulation in the HIV-infected patient

Aug. 18, 1998

Anti-HIV agents, protease inhibitors, patented by DuPont Merck

Aug. 14, 1998

Third center begins inoculating subjects in AIDSVAX trial

Aug. 12, 1998

Searle presents new HIV protease inhibitor series

Aug. 10, 1998

Japan Energy prepares HIV protease-inhibitory dipeptides

July 31, 1998

Celgene reports encouraging results from AIDS wasting study with Thalomid

July 30, 1998

Advanced Viral Research to initiate clinical trials with Reticulose in Mexico

July 28, 1998

Italian university researchers investigate peptidomimetic HIV protease inhibitors

July 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...